Sec. 1. Short title; table of contents

2,197 words·~10 min read·/bill/115/hr/6/pcs/section-1

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

This Act may be cited as the or the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act . SUPPORT for Patients and Communities Act The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Title I—Medicaid Provisions to Address the Opioid Crisis Sec. 1001. At-risk youth Medicaid protection. Sec. 1002. Health Insurance for Former Foster Youth. Sec. 1003. Demonstration project to increase substance use provider capacity under the Medicaid program.

Sec. 1004. Drug management program for at-risk beneficiaries. Sec. 1005. Medicaid drug review and utilization. Sec. 1006. Guidance to improve care for infants with neonatal abstinence syndrome and their mothers; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder. Sec. 1007. Medicaid health homes for opioid-use-disorder Medicaid enrollees. Title II—Medicare Provisions to Address the Opioid Crisis Sec. 2001. Authority not to apply certain Medicare telehealth requirements in the case of certain treatment of a substance use disorder or co-occurring mental health disorder.

Sec. 2002. Encouraging the use of non-opioid analgesics for the management of post-surgical pain. Sec. 2003. Requiring a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination. Sec. 2004. Modification of payment for certain outpatient surgical services. Sec. 2005. Requiring e-prescribing for coverage of covered part D controlled substances. Sec. 2006. Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries.

Sec. 2007. Medicare coverage of certain services furnished by opioid treatment programs. Title III—Other Health Provisions to Address the Opioid Crisis Sec. 3001. Clarifying FDA regulation of non-addictive pain and addiction therapies. Sec. 3002. Surveillance and Testing of Opioids to Prevent Fentanyl Deaths. Sec. 3003. Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders. Sec. 3004. High-quality, evidence-based opioid analgesic prescribing guidelines and report.

Sec. 3005. Report on opioids prescribing practices for pregnant women. Sec. 3006. Guidelines for prescribing naloxone. Sec. 3007. Requiring a survey of substance use disorder treatment providers receiving Federal funding. Title IV—Offsets Sec. 4001. Promoting value in Medicaid managed care. Sec. 4002. Extending period of application of Medicare secondary payer rules for individuals with end stage renal disease. Sec. 4003. Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program.

Title V—Other Medicaid Provisions Subtitle A—Mandatory reporting with respect to adult behavioral health measures Sec. 5001. Mandatory reporting with respect to adult behavioral health measures. Subtitle B—Medicaid IMD Additional Info Sec. 5011. Short title. Sec. 5012. MACPAC exploratory study and report on institutions for mental diseases requirements and practices under Medicaid. Subtitle C—CHIP Mental Health Parity Sec. 5021. Short title. Sec. 5022. Ensuring access to mental health and substance use disorder services for children and pregnant women under the Children’s Health Insurance Program.

Subtitle D—Medicaid Reentry Sec. 5031. Short title. Sec. 5032. Promoting State innovations to ease transitions integration to the community for certain individuals. Subtitle E—Medicaid Partnership Sec. 5041. Short title. Sec. 5042. Medicaid providers are required to note experiences in record systems to help in-need patients. Title VI—Other Medicare Provisions Subtitle A—Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology Sec. 6001.

Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology. Subtitle B—Abuse Deterrent Access Sec. 6011. Short title. Sec. 6012. Study on abuse-deterrent opioid formulations access barriers under Medicare. Subtitle C—Medicare Opioid Safety Education Sec. 6021. Short title. Sec. 6022. Provision of information regarding opioid use and pain management as part of Medicare & You handbook. Subtitle D—Opioid Addiction Action Plan Sec. 6031.

Short title. Sec. 6032. Action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment. Subtitle E—Advancing High Quality Treatment for Opioid Use Disorders in Medicare Sec. 6041. Short title. Sec. 6042. Opioid use disorder treatment demonstration program. Subtitle F—Responsible Education Achieves Care and Healthy Outcomes for Users’ Treatment Sec. 6051. Short title. Sec. 6052. Grants to provide technical assistance to outlier prescribers of opioids.

Subtitle G—Preventing Addiction for Susceptible Seniors Sec. 6061. Short title. Sec. 6062. Electronic prior authorization for covered part D drugs. Sec. 6063. Program integrity transparency measures under Medicare parts C and D. Sec. 6064. Expanding eligibility for medication therapy management programs under part D. Sec. 6065. Medicare notifications to outlier prescribers of opioids. Sec. 6066. No additional funds authorized. Subtitle H—Expanding Oversight of Opioid Prescribing and Payment Sec. 6071.

Short title. Sec. 6072. Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program. Sec. 6073. No additional funds authorized. Subtitle I—Dr. Todd Graham Pain Management, Treatment, and Recovery Sec. 6081. Short title. Sec. 6082. Review and adjustment of payments under the Medicare outpatient prospective payment system to avoid financial incentives to use opioids instead of non-opioid alternative treatments. Sec. 6083.

Expanding access under the Medicare program to addiction treatment in Federally qualified health centers and rural health clinics. Sec. 6084. Studying the availability of supplemental benefits designed to treat or prevent substance use disorders under Medicare Advantage plans. Sec. 6085. Clinical psychologist services models under the Center for Medicare and Medicaid Innovation; GAO study and report. Sec. 6086. Pain management study. Subtitle J—Combating Opioid Abuse for Care in Hospitals Sec. 6091.

Short title. Sec. 6092. Developing guidance on pain management and opioid use disorder prevention for hospitals receiving payment under part A of the Medicare program. Sec. 6093. Requiring the review of quality measures relating to opioids and opioid use disorder treatments furnished under the medicare program and other federal health care programs. Sec. 6094. Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative opioid use. Sec. 6095.

Requiring the posting and periodic update of opioid prescribing guidance for Medicare beneficiaries. Subtitle K—Stop Excessive Narcotics in our Retirement Communities Protection Sec. 6101. Short title. Sec. 6102. Suspension of payments by Medicare prescription drug plans and MA–PD plans pending investigations of credible allegations of fraud by pharmacies. Subtitle L—Providing Reliable Options for Patients and Educational Resources Sec. 6111. Short title. Sec. 6112. Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain.

Sec. 6113. Requiring Medicare Advantage plans and prescription drug plans to provide information on the safe disposal of prescription drugs. Sec. 6114. Revising measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management. Title VII—Other Health Provisions Subtitle A—Synthetic Drug Awareness Sec. 7001. Short title. Sec. 7002. Report on effects on public health of synthetic drug use. Subtitle B—Empowering Pharmacists in the Fight Against Opioid Abuse Sec. 7011.

Short title. Sec. 7012. Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription. Subtitle C—Indexing Narcotics, Fentanyl, and Opioids Sec. 7021. Short title. Sec. 7022. Establishment of substance use disorder information dashboard. Sec. 7023. Interagency Substance Use Disorder Coordinating Committee. Subtitle D—Ensuring Access to Quality Sober Living Sec. 7031. Short title. Sec. 7032. National recovery housing best practices.

Subtitle E—Advancing Cutting Edge Research Sec. 7041. Short title. Sec. 7042. Unique research initiatives. Subtitle F—Jessie’s Law Sec. 7051. Short title. Sec. 7052. Inclusion of opioid addiction history in patient records. Sec. 7053. Communication with families during emergencies. Subtitle G—Safe Disposal of Unused Medication Sec. 7061. Short title. Sec. 7062. Disposal of controlled substances of a deceased hospice patient by employees of a qualified hospice program. Subtitle H—Substance Use Disorder Workforce Loan Repayment Sec. 7071.

Short title. Sec. 7072. Loan repayment program for substance use disorder treatment employees. Subtitle I—Preventing Overdoses While in Emergency Rooms Sec. 7081. Short title. Sec. 7082. Program to support emergency room discharge and care coordination for drug overdose patients. Subtitle J—Alternatives to Opioids in the Emergency Department Sec. 7091. Short title. Sec. 7092. Emergency department alternatives to opioids demonstration program. Subtitle K—Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Sec. 7101.

Short title. Sec. 7102. Detention, refusal, and destruction of drugs offered for importation. Sec. 7103. Notification, nondistribution, and recall of adulterated or misbranded drug products. Sec. 7104. Single source pattern of shipments of adulterated or misbranded drugs. Sec. 7105. Fund to strengthen efforts of FDA to combat the opioid and substance use epidemic. Sec. 7106. Consideration of potential for misuse and abuse required for drug approval. Subtitle L—Treatment, Education, and Community Help to Combat Addiction Sec. 7111.

Short title. Sec. 7112. Establishment of Regional Centers of Excellence in Substance Use Disorder Education. Subtitle M—Guidance from National Mental Health and Substance Use Policy Laboratory Sec. 7121. Guidance from National Mental Health and Substance Use Policy Laboratory. Subtitle N—Comprehensive Opioid Recovery Centers Sec. 7131. Short title. Sec. 7132. Comprehensive opioid recovery centers. Subtitle O—Poison Center Network Enhancement Sec. 7141. Short title. Sec. 7142.

Reauthorization of poison control centers national toll-free number. Sec. 7143. Reauthorization of nationwide public awareness campaign to promote poison control center utilization. Sec. 7144. Reauthorization of the poison control center grant program. Subtitle P—Eliminating Opioid Related Infectious Diseases Sec. 7151. Short title. Sec. 7152. Reauthorization and expansion of program of surveillance and education regarding infections associated with illicit drug use and other risk factors.

Subtitle Q—Better Pain Management Through Better Data Sec. 7161. Short title. Sec. 7162. Guidance addressing alternative approaches to data collection and labeling claims for opioid sparing. Subtitle R—Special Registration for Telemedicine Clarification Sec. 7171. Short title. Sec. 7172. Deadline for interim final regulations for a special registration To engage in the practice of telemedicine. Subtitle S—Peer Support Communities of Recovery Sec. 7181. Short title. Sec. 7182.

Building communities of recovery. Subtitle T—Stop Illicit Drug Importation Sec. 7191. Short title. Sec. 7192. Detention, refusal, and destruction of drugs offered for importation. Sec. 7193. Seizure. Sec. 7194. Debarring violative individuals or companies. Subtitle U—Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Sec. 7201. Short title. Sec. 7202. Preventing overdoses of controlled substances. Sec. 7203. Prescription drug monitoring program.

Subtitle V—Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Sec. 7211. Short title. Sec. 7212. Improved technologies, controls, or measures with respect to the packaging or disposal of certain drugs. Subtitle W—Postapproval study requirements Sec. 7221. Postapproval study requirements. Title VIII—Miscellaneous Subtitle A—Synthetics Trafficking and Overdose Prevention Sec. 8001. Short title; table of contents. Sec. 8002. Customs fees. Sec. 8003. Mandatory advance electronic information for postal shipments.

Sec. 8004. International postal agreements. Sec. 8005. Cost recoupment. Sec. 8006. Development of technology to detect illicit narcotics. Sec. 8007. Civil penalties for postal shipments. Sec. 8008. Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest. Sec. 8009. Effective date; regulations. Subtitle B—Recognizing Early Childhood Trauma Related to Substance Abuse Sec. 8011. Short title. Sec. 8012. Recognizing Early Childhood Trauma Related to Substance Abuse.

Subtitle C—Assisting States’ Implementation of Plans of Safe Care Sec. 8021. Short title. Sec. 8022. Assisting States with implementation of plans of safe care. Subtitle D—Improving the Federal Response to Families Impacted by Substance Use Disorder Sec. 8031. Short title. Sec. 8032. Interagency Task Force to Improve the Federal Response to Families Impacted by Substance Use Disorders. Subtitle E—Establishment of an Advisory Committee on Opioids and the Workplace Sec. 8041. Establishment of an Advisory Committee on Opioids and the Workplace.

Subtitle F—Veterans Treatment Court Improvement Sec. 8051. Short title. Sec. 8052. Hiring by Department of Veterans Affairs of additional Veterans Justice Outreach Specialists. Subtitle G—Peer support counseling program for women veterans Sec. 8061. Peer support counseling program for women veterans. Subtitle H—Treating Barriers to Prosperity Sec. 8071. Short title. Sec. 8072. Drug abuse mitigation initiative. Subtitle I—Supporting Grandparents Raising Grandchildren Sec. 8081.

Short title. Sec. 8082. Findings. Sec. 8083. Advisory Council To Support Grandparents Raising Grandchildren. Sec. 8084. Definitions. Subtitle J—Reauthorizing and Extending Grants for Recovery from Opioid Use Programs Sec. 8091. Short title. Sec. 8092. Reauthorization of the comprehensive opioid abuse grant program. Title IX—SITSA Act Sec. 9001. Short title. Sec. 9002. Establishment of schedule A. Sec. 9003. Temporary and permanent scheduling of schedule A substances. Sec. 9004.

Penalties. Sec. 9005. False labeling of schedule A controlled substances. Sec. 9006. Registration requirements for handlers of schedule A substances. Sec. 9007. Additional conforming amendments. Sec. 9008. Controlled substance analogues. Sec. 9009. Rules of construction. Sec. 9010. Study by Comptroller General. Sec. 9011. Report on controlled substance analogues sold by means of the Internet. Sec. 9012. Controlled substance analogues. Title X—THRIVE Act Sec. 10001. Short title.

Sec. 10002. Demonstration program to study the impact of using rental vouchers for supportive housing for individuals recovering from opioid use disorders or other substance use disorders. Sec. 10003. Repeal of Rental Voucher Demonstration Program. Sec. 10004. Demonstration Close-Out. Sec. 10005. No additional funds authorized. Title XI—IMD CARE Act Sec. 11001. Short title. Sec. 11002. Medicaid State plan option to provide services for certain individuals with targeted SUDs in institutions for mental diseases.

Sec. 11003. Promoting value in Medicaid managed care.